Navigation Links
SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results
Date:7/26/2011

nd 49,816,073 issued and outstanding as of June 30, 2011, and December 31, 2010

49

49Additional paid-in capital

77,989

77,041Accumulated deficit

(75,810)

(74,049)Total stockholders' equity

2,228

3,041$  3,178

$  3,858(1) restated SCOLR Pharma, Inc.UNAUDITED CONDENSED STATEMENTS OF OPERATIONS(In thousands, except per share amounts)Three months endedJune 30,Six months endedJune 30,20112010(1)20112010(1)RevenuesLicensing fees$

-$

100$

-$

125Royalty income812374264Research and development --118-   Total revenues8223192389Operating expensesMarketing and selling5386178145Research and development(103)256544596General and administrative5855721,3251,173Total operating expenses5359142,0471,914Loss from operations(527)(691)(1,855)(1,525)Other income (expense)Interest income--11Interest expense(5)-(5)-Unrealized gain (loss) on fair value of warrant(8)225977Other1(15)1(15)Total other income (expense)(12)21094(7)Net loss$

(539)$

(481)$

(1,761)$

(1,532)Net loss per share, basic and diluted$

(0.01)$

(0.01)$

(0.04)$

(0.03)Shares used in computing basic and diluted net loss per share49,81649,68449,81646,430(1) restated Contacts:
Investor Relations:
SCOLR Pharma, Inc.
425.368.1050


'/>"/>
SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. SCOLR Pharma, Inc. First Quarter 2011 Financial Results
2. SCOLR Pharma, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference
3. SCOLR Pharma, Inc. Reports 2010 Financial Results, Provides Updates on Advances in Nutritionals, OTC Drugs
4. SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
5. SCOLR Pharma, Inc. Retains Nicholas Hall & Company
6. SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011
7. SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist From NYSE AMEX Exchange
8. SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
9. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
10. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
11. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 Echo Therapeutics, Inc. (NASDAQ: ... on skin permeation, continuous glucose monitoring and associated ... has been appointed Chief Executive Officer effective ... 20 years of experience in the medical device, ... served as Vice President, Business Development, Otsuka Pharmaceuticals as ...
(Date:12/24/2014)... 23, 2014   Assurex Health, a personalized ... healthcare providers for behavioral health and chronic pain ... million in equity financing from new and existing ... President and Chief Executive Officer. The ... of Assurex Health,s GeneSight ®  products.  ...
(Date:12/24/2014)... DUBLIN and RALEIGH, N.C. ... subsidiary of Endo International plc (NASDAQ: ENDP ... BDSI ) announced today that they have ... Buccal Film to the U.S. Food and Drug Administration ... the management of pain severe enough to require daily, ...
Breaking Medicine Technology:Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
... Oct. 12 Ethicon Endo-Surgery, Inc., today ... at the 95th Annual Clinical Congress of the ... technologies of worldwide leading HARMONIC® ultrasonic and ENSEAL® ... delivery options that provide superior energy application for ...
... 12 Stereotaxis, Inc. (Nasdaq: STXS ) announced today ... Stereotaxis common stock have exercised in full their over-allotment option ... stock. The 7,475,000 shares of Stereotaxis common stock in ... option, are being sold at a price to the public ...
Cached Medicine Technology:Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress 2Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress 3Stereotaxis Announces Underwriters' Exercise of Over-Allotment Option 2Stereotaxis Announces Underwriters' Exercise of Over-Allotment Option 3
(Date:12/26/2014)... England (PRWEB) December 26, 2014 The ... take place March 24-28, 2015 in Rome, Italy and ... line-up includes workshops on a wide variety ... as well as peak performance training in athletes. The ... around the world. , Biofeedback monitoring allows clients to ...
(Date:12/26/2014)... India Network Foundation, a non-profit US based ... today a new version of “ EasySelect ”, a ... plan for their visiting parents. The technology tool is ... process when choosing an insurance plan by showing the ... few clicks. Many elderly Asian Indian parents often find ...
(Date:12/26/2014)... December 26, 2014 Parker & ... the best in heating, cooling and plumbing contractor ... hour emergency services in 2014 with regard to ... that Arizona is known for its incredibly hot ... understands the intricacies and details of a wide ...
(Date:12/25/2014)... December 26, 2014 The ... combines beauty, strength and durability. Today, the business ... which is valid until Jan. 30, 2015. , ... of traditional hardwood. BambooFlooringChina.com is a well-known brand ... consumers worldwide to find a reliable bamboo flooring ...
(Date:12/25/2014)... 25, 2014 Product liability lawsuits filed ... recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in ... Order issued in the U.S. District Court, Northern District ... an open conference on January 7, 2015, at the ... in West Palm Beach, Florida. The Conference is scheduled ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3
... scheduled for November 6, 2008 at 1:30 p.m. (Pacific); ... simultaneous webcast at http://www.adventrx.com , SAN DIEGO, ... that it will host a conference call with,simultaneous webcast to discuss ... Pacific / 4:30 p.m. Eastern. Mark N. K.,Bagnall, Executive Vice President ...
... "Elect to Save Your Feet," Get Annual Foot Check-ups, ... across the globe battle diabetes and its complications every ... in time to prevent,serious amputations, according to a recent ... APMA study, conducted by an independent research firm, found ...
... of novel therapeutics, and the rapidly aging population, the world market ... just two therapy classes - vitamin K antagonist and heparin injectables, ... advanced, patient friendly anticoagulants. , ... San Jose, CA ...
... Skin Appearance Beauty Product!,Selfridges is the UK,s exclusive retail provider of ... the appearance of wrinkles and fine lines, while nourishing and deodorizing ... ... and Greensboro, NC (PRWEB) October 30, 2008 -- Selfridges & Co. ...
... GMA Senior Vice President and Chief Science & Regulatory Affairs Officer ... report on the safety assessment of bisphenol A. , ... ... Association (GMA) today issued the following statement from GMA Senior Vice ...
... nationally-aired commercial with Jenny,Craig celebrity client, Valerie Bertinelli, ... is pleased to,announce the three grand finalists of ... natives Elaina Faustino and,Sara Hennessy are the three ... a,national TV commercial with Jenny Craig star client, ...
Cached Medicine News:Health News:Study Finds Preventative Diabetes Care Reduces Amputation Occurrence 2Health News:World Anticoagulants Market to Exceed $12 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 2Health News:World Anticoagulants Market to Exceed $12 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 3Health News:Selfridges and Cupron Bring Actual Beauty Sleep to Brits 2Health News:Selfridges and Cupron Bring Actual Beauty Sleep to Brits 3Health News:Selfridges and Cupron Bring Actual Beauty Sleep to Brits 4Health News:Grocery Manufacturers Association Statement Regarding FDA Science Board Advisory Report on Bisphenol A (BPA) 2Health News:Jenny Craig Announces Finalists for the 2008 Ideal Size Contest 2
... Low profile-general purpose refrigerated. The ... with B/D Vacutainer tubes (meeting US ... culture with 15/50 ml Falcon/Corning conicals, ... ml bottles, genomic/proteomic microplate pelleting and ...
... versatility. This is an refrigerated centrifuge ... to +25C. Automatic acceleration, de-acceleration with ... switch, modular disk adapters, stacked design ... tubes and rotor imbalance protection provides ...
... The Spinchron 15 centrifuge ... high capacity needed for today's ... refrigerated model has a speed ... the ability to spin tubes, ...
Sealed Aero-Lok technology centrifuge. AeroLok technology, a brush less permanently lubricated motor, sturdy aluminum cabinet is covered with a durable, baked-on powder coating in an attractive tan c...
Medicine Products: